Leen Ann M. (CIK 0001763026)

Latest company ownership

KLRS - Kalaris Therapeutics, Inc.
Role: Chief Scientific Officer
Shares held
2,288,154
Last filed at
Feb 3, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 12, 2021 Nov 16, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -20,988 -0.90% ✓ $465.6K
May 10, 2021 May 10, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 17.5 -150,000 -6.03% ✗ $3.4M
Mar 16, 2021 Mar 18, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 50.0 -3,025 -0.12% ✓ $90.8K
Mar 1, 2021 Mar 3, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -9,518 -0.38% ✓ $368.3K
Feb 19, 2021 Feb 23, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -17,446 -0.69% ✓ $723.6K
Feb 18, 2021 Feb 19, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 50.0 -2,700 -0.11% ✓ $110.2K
Feb 16, 2021 Feb 18, 2021 Kalaris Therapeutics, Inc. Chief Scientific Officer Sell 50.0 -5,336 -0.21% ✓ $220.2K